Total Payments
$14,108
2024 Payments
$2,542
Companies
59
Transactions
630
Medicare Patients
11,403
Medicare Billing
$928,806
Payment Breakdown by Category
Food & Beverage$12,432 (88.1%)
Education$1,542 (10.9%)
Travel$134.09 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,432 | 591 | 88.1% |
| Education | $1,542 | 38 | 10.9% |
| Travel and Lodging | $134.09 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,756 | 84 | $0 (2024) |
| Janssen Biotech, Inc. | $1,350 | 60 | $0 (2024) |
| ABBVIE INC. | $696.34 | 52 | $0 (2024) |
| PFIZER INC. | $679.12 | 38 | $0 (2024) |
| Antares Pharma, Inc. | $668.65 | 27 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $623.46 | 14 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $609.54 | 29 | $0 (2024) |
| COLOPLAST CORP | $577.97 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $463.21 | 19 | $0 (2024) |
| Amgen Inc. | $440.58 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,542 | 94 | Sumitomo Pharma America, Inc. ($294.18) |
| 2023 | $2,789 | 90 | C. R. Bard, Inc. & Subsidiaries ($436.36) |
| 2022 | $2,086 | 105 | Janssen Biotech, Inc. ($260.81) |
| 2021 | $1,070 | 43 | Astellas Pharma US Inc ($160.92) |
| 2020 | $744.08 | 38 | Astellas Pharma US Inc ($182.67) |
| 2019 | $1,751 | 86 | Astellas Pharma US Inc ($397.58) |
| 2018 | $1,497 | 90 | Astellas Pharma US Inc ($183.87) |
| 2017 | $1,627 | 84 | Astellas Pharma US Inc ($318.27) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Vitrakvi, Stivarga | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $29.52 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $52.48 | General |
| Category: HORMONE THERAPY | ||||||
| 12/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $48.80 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/19/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Urology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $15.70 | General |
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.17 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,626 | 7,597 | $675,814 | $210,852 |
| 2022 | 18 | 2,764 | 9,593 | $711,735 | $246,778 |
| 2021 | 23 | 2,886 | 8,623 | $759,483 | $263,888 |
| 2020 | 25 | 3,127 | 5,545 | $692,026 | $207,288 |
Total Patients
11,403
Total Services
31,358
Medicare Billing
$928,806
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 476 | 806 | $191,022 | $76,597 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 330 | 390 | $62,790 | $25,826 | 41.1% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 327 | 440 | $118,800 | $19,648 | 16.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 62 | 86 | $65,704 | $16,179 | 24.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 119 | $39,389 | $16,034 | 40.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 16 | 3,520 | $17,600 | $11,223 | 63.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $30,530 | $10,868 | 35.6% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 17 | 17 | $36,028 | $9,739 | 27.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 480 | 722 | $43,320 | $6,145 | 14.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 15 | 17 | $24,434 | $6,092 | 24.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 50 | 56 | $16,968 | $5,040 | 29.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 665 | 1,105 | $6,630 | $2,429 | 36.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 32 | 61 | $6,100 | $1,780 | 29.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 157 | $12,089 | $1,640 | 13.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,410 | $1,613 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 493 | 805 | $190,903 | $81,505 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 324 | 383 | $61,663 | $26,981 | 43.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 73 | 107 | $69,810 | $21,878 | 31.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 26 | 154 | $50,974 | $21,571 | 42.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 127 | 162 | $47,134 | $16,881 | 35.8% |
| J9155 | Injection, degarelix, 1 mg | Office | 2022 | 18 | 5,120 | $25,600 | $16,357 | 63.9% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 231 | 286 | $77,220 | $13,534 | 17.5% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 22 | 22 | $39,336 | $12,162 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 88 | 88 | $31,240 | $11,466 | 36.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 531 | 865 | $51,900 | $7,594 | 14.6% |
About Anthony Kim, M. D
Anthony Kim, M. D is a Urology healthcare provider based in Middlebury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205890381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Kim, M. D has received a total of $14,108 in payments from pharmaceutical and medical device companies, with $2,542 received in 2024. These payments were reported across 630 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($12,432).
As a Medicare-enrolled provider, Kim has provided services to 11,403 Medicare beneficiaries, totaling 31,358 services with total Medicare billing of $928,806. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Middlebury, CT
- Active Since 04/14/2006
- Last Updated 09/10/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1205890381
Products in Payments
- XTANDI (Drug) $1,202
- ERLEADA (Drug) $732.11
- Bard Urinary Drainage Bag (Device) $603.90
- XYOSTED (Drug) $569.06
- GEMTESA (Drug) $564.16
- Natesto (Drug) $529.16
- SPEEDICATH (Device) $495.25
- KEYTRUDA (Biological) $443.16
- ORGOVYX (Drug) $366.37
- ELIGARD (Drug) $314.02
- LUPRON DEPOT (Drug) $307.15
- PROVENGE (Drug) $300.41
- Prolia (Biological) $296.33
- Erleada (Drug) $272.42
- Sonablate (Device) $272.28
- PYLARIFY (Drug) $270.59
- XIAFLEX (Biological) $259.13
- AQUABEAM SYSTEM (Device) $240.81
- Nubeqa (Drug) $240.31
- ZYTIGA (Drug) $230.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Middlebury
York Moy, M.d, M.D
Urology — Payments: $19,679
Urology $19,679
Sagar Phatak, M. D, M. D
Urology — Payments: $11,014
Urology $11,014
Michael Flanagan, M.d, M.D
Urology — Payments: $8,362
Urology $8,362
Joseph Antoci, M. D, M. D
Urology — Payments: $100.28
Urology $100.28
Robert Feldman, M.d, M.D
Urology — Payments: $83.85
Urology $83.85